Pulmonary tumor thrombotic microangiopathy from metastatic epithelioid angiosarcoma


Demirag F., Cakir E., Yazici U., Tastepe I.

JOURNAL OF THORACIC DISEASE, cilt.5, sa.3, 2013 (SCI-Expanded) identifier identifier identifier

Özet

The lung is most common site for metastatic disease via hematogenous route. Tumor emboli of the vessels of the lung induces fibrocellular and fibromuscular intimal proliferation. These histopathological changes may cause pulmonary tumor trombotic microangiopaty. Few cases are diagnosed antemortem. We report a 60 year old woman with by metastatic epithelioid angiosarcoma involving the lung. Tumor cells were positive for VEGF and topoisomerase II. VEGF may be involved in the pathogenesis pulmonary tumor trombotic microangioapy and topoisomerase II positivity showed sensitivity against catalytic topoisomerase II inhibitors.